Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session 3

2995 - Dysregulation of helper T lymphocytes in esophageal squamous cell carcinoma (ESCC) patients is highly associated with aberrant production of miR-21


30 Sep 2019


Poster Display session 3


Translational Research

Tumour Site


Ali Memarian


Annals of Oncology (2019) 30 (suppl_5): v760-v796. 10.1093/annonc/mdz268


A. Memarian1, H. Samiei2, B. Sedighi-Moghaddam3, S. Mohammadi4, A. Gharavi5, S. Abdolmaleki6, M. Jeddi-Tehrani7

Author affiliations

  • 1 Golestan Research Center Of Gastroenterology And Hepatology, Golestan University of Medical Sciences, 49186-36316 - Gorgan/IR
  • 2 Student Research Committee, Semnan University of medical Sciences, 14324 - semnan/IR
  • 3 Immunology, Medicine, Semnan University of medical Sciences, 14324 - semnan/IR
  • 4 Stem Cell Research Center, Golestan University of Medical Sciences, 14324 - Gorgan/IR
  • 5 Golestan Research Center Of Gastroenterology And Hepatology, Golestan University of Medical Sciences, 14324 - Gorgan/IR
  • 6 Student Research Committee, Mazandaran University of Medical Sciences, 14324 - Sari/IR
  • 7 Immunology, Monoclonal Antibody Research Center, Avicenna Research Institute, 143242211 - Tehran/IR


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 2995


Dysregulation of helper T (Th) cell subsets has been contributed to the initiation and propagation of esophageal squamous cell carcinoma (ESCC). Different microRNAs (miRNAs) have been reported to control the development and functions of tumor-associated immune cells in ESCC. Here, we aimed to assess the IL-10, TGF-β, IFN-γ and IL-17a producing CD3+CD8- T cells in association whit miR-21, miR-29b, miR-106a and miR-155 expression in ESCC patients.


A total of 34 ESCC patients including 12 newly diagnosed (ND) and 22 under-treatment (UT) cases and 34 age-matched healthy donors were enrolled. Flowcytometric characterization of stimulated T cells was performed by staining cells with fluorescent conjugated specific anti human CD3 and CD8 cell surface markers as well as IL-17a, IFN-γ, IL-10 and TGF-β intracytoplasmic cytokines. Circulating RNA was extracted from the plasma and qRT-PCR was used to evaluate the expression of miR-21 and miR-29b. TGF-β plasma levels were also assessed by ELISA.


The frequency of Th cells was significantly reduced in EC Patients. A significant increase in Tregs as well as Th17 cells population in both patient subgroups was observed. ND patients showed elevated level of Th1 cells and IL-10. However, the expression of IFN-γ was significantly decreased in Th cells. We also detected higher level of miR-21 in the ESCC patients which was significantly correlated with different subsets of Th cell.


Our findings revealed that immune response related Th cells is highly impaired in ESCC patients and association between miR-21 and Th subsets could be correlated with the impairment of anti-tumor immunity and consequently ESCC pathogenesis which might be potentially used as an important target for immunotherapy.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.


Golestan University of Medical Sciences; Semnan University of Medical Sciences.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.